Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Qi Wu, Xingxing Wu, Mao Wang, Kexin Liu, Yuge Li, Xiaoyu Ruan, Lin Qian, Lingchang Meng, Zhiting Sun, Lei Zhu, Jing Wu & Genglin Mu. (2023) Therapeutic Mechanism of Baicalin in Experimental Colitis Analyzed Using Network Pharmacology and Metabolomics. Drug Design, Development and Therapy 17, pages 1007-1024.
Read now
Read now
Samira Nasiri Kolahi, Zivar Salehi, Soheila Talesh Sasani, Farhad Mashayekhi & Keyvan Aminian. (2023) Polymorphisms of miR-146a and susceptibility to ulcerative colitis risk: a case-control study. Nucleosides, Nucleotides & Nucleic Acids 42:3, pages 206-216.
Read now
Read now
Chunhua Yang & Didier Merlin. (2019) Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives. International Journal of Nanomedicine 14, pages 8875-8889.
Read now
Read now
Marla C. Dubinsky. (2017) Reviewing treatments and outcomes in the evolving landscape of ulcerative colitis. Postgraduate Medicine 129:5, pages 538-553.
Read now
Read now
Sneha G. Nair, Jaivik V. Shah, Priyanka A. Shah, Mallika Sanyal & Pranav S. Shrivastav. (2015) Extractive spectrophotometric determination of five selected drugs by ion-pair complex formation with bromothymol blue in pure form and pharmaceutical preparations. Cogent Chemistry 1:1.
Read now
Read now
Omri Wolk, Svetlana Epstein, Viktoriya Ioffe-Dahan, Shimon Ben-Shabat & Arik Dahan. (2013) New targeting strategies in drug therapy of inflammatory bowel disease: mechanistic approaches and opportunities. Expert Opinion on Drug Delivery 10:9, pages 1275-1286.
Read now
Read now
Articles from other publishers (4)
Alaa Bagalagel, Reem Diri, Ahmad Noor, Deina Almasri, Hussain T. Bakhsh, Hussam I. Kutbi & Mohammed M. H. Al‐Gayyar. (2022) The therapeutic effects of cycloastragenol in ulcerative colitis by modulating SphK/MIP‐1α/miR‐143 signalling. Basic & Clinical Pharmacology & Toxicology 131:5, pages 406-419.
Crossref
Crossref
Mukta Gupta, Vijay Mishra, Monica Gulati, Bhupinder Kapoor, Amrinder Kaur, Reena Gupta & Murtaza M. Tambuwala. (2022) Natural compounds as safe therapeutic options for ulcerative colitis. Inflammopharmacology 30:2, pages 397-434.
Crossref
Crossref
Henusha D. Jhundoo, Tobias Siefen, Alfred Liang, Christoph Schmidt, John Lokhnauth, Arnaud Béduneau, Yann Pellequer, Crilles Casper Larsen & Alf Lamprecht. (2020) Anti-Inflammatory Activity of Chitosan and 5-Amino Salicylic Acid Combinations in Experimental Colitis. Pharmaceutics 12:11, pages 1038.
Crossref
Crossref
Alex Yu, Jason R. Baker, Ann F. Fioritto, Ying Wang, Ruijuan Luo, Siwei Li, Bo Wen, Michael Bly, Yasuhiro Tsume, Mark J. Koenigsknecht, Xinyuan Zhang, Robert Lionberger, Gordon L. Amidon, William L. Hasler & Duxin Sun. (2016)
Measurement of
in vivo
Gastrointestinal Release and Dissolution of Three Locally Acting Mesalamine Formulations in Regions of the Human Gastrointestinal Tract
. Molecular Pharmaceutics 14:2, pages 345-358.
Crossref
Crossref